Geert Verheyden on Advancing Stroke Rehabilitation Through Collaboration and Innovation
Geert Verheyden, Professor and Stroke Rehabilitation Research Lead at KU Leuven, shared on LinkedIn:
”Looking back at 2025 and looking ahead to 2026…
Marjan Coremans analyzed clinical and cost-effectiveness of high-dose motor rehabilitation in 101 people with stroke and SCI and this collaboration with AZ Herentals, To Walk Again and Koen Putman and Maaike Fobelets from I-CHER Vrije Universiteit Brussel will see the presentation of key results in 2026 (protocol in preprint)
Liesel Cornelis and the AHA-BOOST team with Jessa Ziekenhuis (Marc Michielsen, Maaiken Vander Plaetse) and Vrije Universiteit Brussel (Koen Putman, Maaike Fobelets, Lisa Cruycke and Ann De Smedt) continued to recruit patients for this trial evaluating upper limb therapy in the early subacute phase after stroke (trial protocol), coordinated by Sarah Meyer
Charlotte Heremans and Siqi Yang collaborated with Inês Martins, Jean-Jacques Orban de Xivry and Jolien Gooijers and piloted a novel intervention for sensorimotor deficits in the upper limb after stroke where clinical, kinematic and neuroimaging (fNIRS and MRI) outcomes will be integrated in a clinical trial starting recruitment in 2026.
Yue Zou joined the team in February and will investigate bimanual activity for the upper limbs after stroke (most recent paper) in partnership with Dante Mantini and Daphne Kos at KU Leuven and Natalie Fini, Kate Hayward and Emily Dalton at University of Melbourne through a global PhD collaboration including Jane Beecher
The team welcomed Aditya Senthil for a Fulbright Association research stay to collaborate with Friedl De Groote and Tom Buurke and work on multiple muscle coherence analysis in people after stroke.
Truly grateful for all these and the other collaborations in the past year, and motivated to continue and strengthen these in 2026!”
Stay updated with Hemostasis Today.
-
Dec 20, 2025, 18:30Kate Scrivener on Cochrane Review: 2025 Ends With a Big Milestone!
-
Dec 20, 2025, 18:15Shekher Bose on AstraZeneca’s Voluntary Withdrawal of Andexxa
-
Dec 20, 2025, 17:10Mina Adel Nagi on the Future of ESR Testing with HORIBA’s CoRA Technology
-
Dec 20, 2025, 16:26Dirk Sibbing on Antithrombotic Drugs for ACS in Women
-
Dec 20, 2025, 16:13Akshat Jain Explains VWF/FVIII Prophylaxis in Children Under 6
-
Dec 20, 2025, 15:49Manuel Requena Shares The Results of the RESISTANT International Registry
-
Dec 20, 2025, 13:49Harshal Kale: Wishing Our Community a Bright Start to 2026
-
Dec 20, 2025, 12:23Healthcare is a Human Right: Strengthening Blood Donation in Armenia
-
Dec 20, 2025, 12:17VTE Risks, Clinical Features, Diagnosis and Management Explained by Samwel Mikaye